Miami Dade County ASsessment of Phylogenetics to Improve Resource Equity: MD ASPIRE
迈阿密戴德县系统发生学评估以改善资源公平:MD ASPIRE
基本信息
- 批准号:10653972
- 负责人:
- 金额:$ 96.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-01 至 2027-04-30
- 项目状态:未结题
- 来源:
- 关键词:AIDS preventionAcuteAffectAreaBlood specimenCodeConsensusCountyDataData AnalysesDecision MakingEconomic ModelsEconomicsEpidemicEquityEvaluationFeedbackFutureGeographyGoalsHIVHIV InfectionsHIV/STDHealthHealth PersonnelHuman ResourcesIncidenceIndividualInfectionInfrastructureInterventionLaboratoriesLinkLos AngelesMeasuresMethodsModelingMolecularOutcomePathway AnalysisPersonsPhylogenetic AnalysisPopulationPrevalencePreventionPrevention programProcessProgram EvaluationPublic HealthReportingResearch PersonnelResource AllocationResourcesRiskServicesSurveillance ProgramTestingUniversitiesViralcostcost effectivenessdata exchangedetection methodefficacy outcomesevidence basehealth equityimplementation strategyimprovedpopulation basedpreventive interventionprogramsprospectiverapid detectionsecondary analysissurveillance datatooltransmission processuser-friendly
项目摘要
ABSTRACT
The Ending the HIV Epidemic (EHE) Initiative boldly aims to reduce HIV incidence in high burden areas by 90%
by 2030, yet challenges remain in measuring incidence to identify priority populations and knowing how to best
allocate local resources. To date, HIV molecular surveillance-based interventions have not been linked to a
reduction in HIV incidence. That is (with rare exception), public health efforts directed to individuals associated
with rapidly growing HIV transmission clusters have not been shown to reduce the number of new HIV infections
or the proportion of people virally suppressed in the regions or groups where these services were delivered.
There are no existing resource allocation models that are informed by local molecular and HIV program data to
determine how to best allocate resources relevant to EHE targets. The “Los Angeles County ASsessment of
Phylodynamics to Improve Resource Equity (LAC ASPIRE)” team will use i) advanced phylodynamic
approaches and prospective measures of incidence to identify populations with the highest transmission rates
in Los Angeles County (LAC) and ii) economic modeling to optimize allocation of public health program resources
to achieve EHE and other stakeholder targets. The ASPIRE team is a partnership between investigators at
several academic universities and the LAC Division of HIV and STD Programs (DHSP). Analyses will use coded
and de-identified HIV surveillance data and program data provided by the LAC DHSP. The proposed study will
identify LAC populations with the highest transmission rates and denote as priority populations. We will use
economic modeling to develop strategies that optimize the allocation of prevention resources to i) reduce HIV
incidence, ii) improve HIV-related health outcomes, and iii) improve equity across populations. We will engage
stakeholders—defined as 1) LAC DHSP personnel, 2) those directly or indirectly involved in administering HIV
Programs in LAC, and 3) persons with HIV (PWH) and other key affected populations—to provide guidance on
population and resource prioritization strategies that are both regionally acceptable and most likely to achieve
EHE targets.
The overall study objective is to develop a process to guide decision-making related to allocation of HIV program
resources by public health departments informed by regional program and transmission data. Project specific
aims include: Aim 1 (IDENTIFY). Identify populations that are the highest priority for HIV prevention efforts (these
data will inform the epidemic model used in Aim 2); Aim 2 (ALLOCATE). Develop a user-friendly dynamic
transmission model that will project the impact of alternative strategies for the optimal allocation of resources to
LAC HIV prevention programs (these data will project health outcomes and cost-effectiveness); and Aim 3
(ENGAGE). Engage key stakeholders to develop a process to guide project outcomes and build capacity at the
LAC Health Department for data analysis that incorporates Aim 1 and 2 methods.
摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SUSAN JANET LITTLE其他文献
SUSAN JANET LITTLE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SUSAN JANET LITTLE', 18)}}的其他基金
Miami Dade County ASsessment of Phylogenetics to Improve Resource Equity: MD ASPIRE
迈阿密戴德县系统发生学评估以改善资源公平:MD ASPIRE
- 批准号:
10460007 - 财政年份:2022
- 资助金额:
$ 96.07万 - 项目类别:
Risks, Benefits, and Stakeholder Perspectives of Molecular Epidemiology for HIV Prevention (HIV-ME)
HIV 分子流行病学预防 (HIV-ME) 的风险、益处和利益相关者观点
- 批准号:
10212958 - 财政年份:2020
- 资助金额:
$ 96.07万 - 项目类别:
Risks, Benefits, and Stakeholder Perspectives of Molecular Epidemiology for HIV Prevention (HIV-ME)
HIV 分子流行病学预防 (HIV-ME) 的风险、益处和利益相关者观点
- 批准号:
10405074 - 财政年份:2020
- 资助金额:
$ 96.07万 - 项目类别:
Risks, Benefits, and Stakeholder Perspectives of Molecular Epidemiology for HIV Prevention (HIV-ME)
HIV 分子流行病学预防 (HIV-ME) 的风险、益处和利益相关者观点
- 批准号:
10640251 - 财政年份:2020
- 资助金额:
$ 96.07万 - 项目类别:
Risks, Benefits, and Stakeholder Perspectives of Molecular Epidemiology for HIV Prevention (HIV-ME)
HIV 分子流行病学预防 (HIV-ME) 的风险、益处和利益相关者观点
- 批准号:
10082384 - 财政年份:2020
- 资助金额:
$ 96.07万 - 项目类别:
Core B: Clinical and Anatomic Pathology Core
核心 B:临床和解剖病理学核心
- 批准号:
10223141 - 财政年份:2017
- 资助金额:
$ 96.07万 - 项目类别:
Efficacy of ART to Interrupt HIV Transmission Networks
ART 阻断 HIV 传播网络的功效
- 批准号:
8658916 - 财政年份:2014
- 资助金额:
$ 96.07万 - 项目类别:
Efficacy of ART to Interrupt HIV Transmission Networks
ART 阻断 HIV 传播网络的功效
- 批准号:
8848139 - 财政年份:2014
- 资助金额:
$ 96.07万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 96.07万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 96.07万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 96.07万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 96.07万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 96.07万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 96.07万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 96.07万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 96.07万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 96.07万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 96.07万 - 项目类别:
Operating Grants